Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers

Abstract Background To analyze the demographic characteristics of retinopathy of prematurity (ROP) in China, attempting to propose optimized screening criteria and hopefully providing valuable information for future updates to the ROP guideline. Methods A multicenter, retrospective-cohort study was...

Full description

Saved in:
Bibliographic Details
Main Authors: Yusheng Zhong, Xiacheng Lin, Yating Yang, Liying He, Na Li, Jun Lu, Yu Zhou, Rong Zhang, Yacong Wang, Zhongyu Zhang, Mochi Yang, Hong Yin, Mingwei Zhao, Xiaoxin Li, Jianhong Liang, Yong Cheng
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-024-03836-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559853874544640
author Yusheng Zhong
Xiacheng Lin
Yating Yang
Liying He
Na Li
Jun Lu
Yu Zhou
Rong Zhang
Yacong Wang
Zhongyu Zhang
Mochi Yang
Hong Yin
Mingwei Zhao
Xiaoxin Li
Jianhong Liang
Yong Cheng
author_facet Yusheng Zhong
Xiacheng Lin
Yating Yang
Liying He
Na Li
Jun Lu
Yu Zhou
Rong Zhang
Yacong Wang
Zhongyu Zhang
Mochi Yang
Hong Yin
Mingwei Zhao
Xiaoxin Li
Jianhong Liang
Yong Cheng
author_sort Yusheng Zhong
collection DOAJ
description Abstract Background To analyze the demographic characteristics of retinopathy of prematurity (ROP) in China, attempting to propose optimized screening criteria and hopefully providing valuable information for future updates to the ROP guideline. Methods A multicenter, retrospective-cohort study was conducted. The study included infants born between January 1, 2018, and July 31, 2023, who underwent ROP screening and were diagnosed with ROP at seven screening centers in China. Examinations were carried out in accordance with the ROP guidelines in 2014: infants with a gestational age (GA)<32 weeks and/or birth weight (BW)<2000 g, or infants who were suspected to be at risk of ROP. ROP treatment followed the recommendations of the Early Treatment for Retinopathy of Prematurity Cooperative Group. We utilized receiver operating characteristic (ROC) curves to determine the optimal predictive model, and conducted internal validation as well as compared the model to current standards. Results Among the 4770 infants diagnosed with ROP after fundus screening, 1330 (27.9%) infants received treatment. The mean GA at birth for all enrolled infants was 29.67 ± 2.45 weeks, with a mean BW of 1295.89 ± 403.64 g. This study proposed the optimization of guidelines to be ≤ 30 weeks of GA and ≤ 1600 g of BW, achieving a sensitivity of 99.4%, as high as the current standard, with an 18.0% reduction in screening requirements. Conclusion Considering the decrease in both GA and BW among the population requiring ROP treatment in China, it is imperative to contemplate updating the ROP screening guideline.
format Article
id doaj-art-fa86b5b139c044e28a4d6868d5509fb4
institution Kabale University
issn 1471-2415
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj-art-fa86b5b139c044e28a4d6868d5509fb42025-01-05T12:11:50ZengBMCBMC Ophthalmology1471-24152025-01-012511810.1186/s12886-024-03836-5Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centersYusheng Zhong0Xiacheng Lin1Yating Yang2Liying He3Na Li4Jun Lu5Yu Zhou6Rong Zhang7Yacong Wang8Zhongyu Zhang9Mochi Yang10Hong Yin11Mingwei Zhao12Xiaoxin Li13Jianhong Liang14Yong Cheng15Department of Ophthalmology, Peking University People’s Hospital, Beijing Key Laboratory of Ocular Disease and Optometry ScienceDepartment of Ophthalmology, Peking University People’s Hospital, Beijing Key Laboratory of Ocular Disease and Optometry ScienceDepartment of Ophthalmology, Peking University People’s Hospital, Beijing Key Laboratory of Ocular Disease and Optometry ScienceWomen and Children’s Hospital of Chongqing Medical UniversityKunming Maternity and Child Care HospitalKunming Maternity and Child Care HospitalMaternal and Child Health Hospital of GuangxiThe Fourth Hospital of ShijiazhuangThe Fourth Hospital of ShijiazhuangDepartment of Ophthalmology, The Second Affiliated Hospital of Harbin Medical UniversityGeneral Hospital of Ningxia Medical UniversityDepartment of Ophthalmology, Peking University People’s Hospital, Beijing Key Laboratory of Ocular Disease and Optometry ScienceDepartment of Ophthalmology, Peking University People’s Hospital, Beijing Key Laboratory of Ocular Disease and Optometry ScienceDepartment of Ophthalmology, Peking University People’s Hospital, Beijing Key Laboratory of Ocular Disease and Optometry ScienceDepartment of Ophthalmology, Peking University People’s Hospital, Beijing Key Laboratory of Ocular Disease and Optometry ScienceDepartment of Ophthalmology, Peking University People’s Hospital, Beijing Key Laboratory of Ocular Disease and Optometry ScienceAbstract Background To analyze the demographic characteristics of retinopathy of prematurity (ROP) in China, attempting to propose optimized screening criteria and hopefully providing valuable information for future updates to the ROP guideline. Methods A multicenter, retrospective-cohort study was conducted. The study included infants born between January 1, 2018, and July 31, 2023, who underwent ROP screening and were diagnosed with ROP at seven screening centers in China. Examinations were carried out in accordance with the ROP guidelines in 2014: infants with a gestational age (GA)<32 weeks and/or birth weight (BW)<2000 g, or infants who were suspected to be at risk of ROP. ROP treatment followed the recommendations of the Early Treatment for Retinopathy of Prematurity Cooperative Group. We utilized receiver operating characteristic (ROC) curves to determine the optimal predictive model, and conducted internal validation as well as compared the model to current standards. Results Among the 4770 infants diagnosed with ROP after fundus screening, 1330 (27.9%) infants received treatment. The mean GA at birth for all enrolled infants was 29.67 ± 2.45 weeks, with a mean BW of 1295.89 ± 403.64 g. This study proposed the optimization of guidelines to be ≤ 30 weeks of GA and ≤ 1600 g of BW, achieving a sensitivity of 99.4%, as high as the current standard, with an 18.0% reduction in screening requirements. Conclusion Considering the decrease in both GA and BW among the population requiring ROP treatment in China, it is imperative to contemplate updating the ROP screening guideline.https://doi.org/10.1186/s12886-024-03836-5Retinopathy of prematurityScreening criteriaChina
spellingShingle Yusheng Zhong
Xiacheng Lin
Yating Yang
Liying He
Na Li
Jun Lu
Yu Zhou
Rong Zhang
Yacong Wang
Zhongyu Zhang
Mochi Yang
Hong Yin
Mingwei Zhao
Xiaoxin Li
Jianhong Liang
Yong Cheng
Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers
BMC Ophthalmology
Retinopathy of prematurity
Screening criteria
China
title Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers
title_full Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers
title_fullStr Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers
title_full_unstemmed Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers
title_short Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers
title_sort screening for retinopathy of prematurity in china a five year cohort study in seven screening centers
topic Retinopathy of prematurity
Screening criteria
China
url https://doi.org/10.1186/s12886-024-03836-5
work_keys_str_mv AT yushengzhong screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT xiachenglin screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT yatingyang screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT liyinghe screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT nali screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT junlu screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT yuzhou screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT rongzhang screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT yacongwang screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT zhongyuzhang screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT mochiyang screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT hongyin screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT mingweizhao screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT xiaoxinli screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT jianhongliang screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters
AT yongcheng screeningforretinopathyofprematurityinchinaafiveyearcohortstudyinsevenscreeningcenters